Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
Australia
Cancer Research South Adelaide, Adelaide, South Australia St Vincent Hospital Melbourne, Melbourne, Victoria